ArticleBone & joint research2026
Serological evidence linking viral infections to incident risk of hip and knee osteoarthritis.
Article in Bone & joint research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Infections, including viral and bacterial agents, can trigger acute arthritis, with some potentially playing a role in the development of chronic arthritis such as osteoarthritis (OA). However, the role of pathogens in OA development remains unexplored. Therefore, this study aimed to investigate the associations between infectious agents and the risk of incident hip and knee OA. Methods: Data were analyzed from 7,352 UK Biobank participants (mean age 56.1 years (SD 8.2); 54.1% female), who were free of hip or knee OA at baseline. A multiplex serology panel measured serum immunoglobulin G antibody levels for 20 infectious agents, including herpesviruses, polyomaviruses, papillomaviruses, retroviruses, hepatitis viruses, bacteria, and protozoa. Incident hip and knee OA were identified through hospital and death registry records. Cox regression was used for the analyses, and the Hochberg method was used for multiple testing correction. Results: Over a median follow-up of 12.7 years (IQR 12.4 to 14.0), 262 participants developed hip and 311 developed knee OA. Seroprevalence rates for the infectious agents ranged from 0.2% to 95.5%. In fully adjusted model, seropositive agents (BK Virus (BKV) (HR 2.88; 95% CI 1.19 to 6.98), Human Papillomavirus type 18 (HPV-18) (HR 1.93; 95% CI 1.03 to 3.65), Kaposi's Sarcoma-Associated Herpesvirus (KSHV) (HR 1.50; 95% CI 1.03 to 2.20), and Merkel Cell Polyomavirus (MCV) (HR 1.40; 95% CI 1.07 to 1.85)) were associated with an increased risk of incident hip OA. Cytomegalovirus (CMV) seropositivity (HR 1.39; 95% CI 1.08 to 1.78) was associated with a higher risk of incident knee OA. BKV, MCV, and CMV remained significant after multiple testing adjustments. Conclusion: This study identified specific viral pathogens associated with an increased risk of incident hip and knee OA, with differences at the knee and hip, suggesting a potential role of preceding infections in OA pathogenesis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.